PristiqExtended-Release (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Pristiq drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| NON-PROPRIETARY NAME: | desvenlafaxine succinate |
| SUBSTANCE NAME: | DESVENLAFAXINE SUCCINATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-04-01 |
| END MARKETING DATE: | 0000-00-00 |
Pristiq Extended-Release HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pristiq Extended-Release from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2015-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0008-1210_2cca96fb-7f9f-4f2d-83ff-3cd6101f56e7 |
| PRODUCT NDC: | 0008-1210 |
| APPLICATION NUMBER: | NDA021992 |
Other DESVENLAFAXINE SUCCINATE Pharmaceutical Manufacturers / Labelers:
